126 related articles for article (PubMed ID: 27468087)
1. Clinical and molecular characteristics of XPO1 mutations in patients with chronic lymphocytic leukemia.
Jain P; Kanagal-Shamanna R; Wierda W; Keating M; Sarwari N; Rozovski U; Thompson P; Burger J; Kantarjian H; Patel KP; Medeiros LJ; Luthra R; Estrov Z
Am J Hematol; 2016 Nov; 91(11):E478-E479. PubMed ID: 27468087
[TBL] [Abstract][Full Text] [Related]
2. Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia.
Walker JS; Hing ZA; Harrington B; Baumhardt J; Ozer HG; Lehman A; Giacopelli B; Beaver L; Williams K; Skinner JN; Cempre CB; Sun Q; Shacham S; Stromberg BR; Summers MK; Abruzzo LV; Rassenti L; Kipps TJ; Parikh S; Kay NE; Rogers KA; Woyach JA; Coppola V; Chook YM; Oakes C; Byrd JC; Lapalombella R
J Hematol Oncol; 2021 Jan; 14(1):17. PubMed ID: 33451349
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, distribution and predictive value of XPO1 mutation in a real-life chronic lymphocytic leukaemia cohort.
Tueur G; Lazarian G; Eclache V; Fleury C; Letestu R; Lévy V; Lefebvre V; Collon JF; Zini JM; Thieblemont C; Soussi T; Cymbalista F; Baran-Marszak F
Br J Haematol; 2020 Nov; 191(3):e90-e94. PubMed ID: 32790071
[No Abstract] [Full Text] [Related]
4. Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1.
Cosson A; Chapiro E; Bougacha N; Lambert J; Herbi L; Cung HA; Algrin C; Keren B; Damm F; Gabillaud C; Brunelle-Navas MN; Davi F; Merle-Béral H; Le Garff-Tavernier M; Roos-Weil D; Choquet S; Uzunov M; Morel V; Leblond V; Maloum K; Lepretre S; Feugier P; Lesty C; Lejeune J; Sutton L; Landesman Y; Susin SA; Nguyen-Khac F
Leukemia; 2017 Jul; 31(7):1625-1629. PubMed ID: 28344316
[No Abstract] [Full Text] [Related]
5. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.
Puente XS; Pinyol M; Quesada V; Conde L; Ordóñez GR; Villamor N; Escaramis G; Jares P; Beà S; González-Díaz M; Bassaganyas L; Baumann T; Juan M; López-Guerra M; Colomer D; Tubío JM; López C; Navarro A; Tornador C; Aymerich M; Rozman M; Hernández JM; Puente DA; Freije JM; Velasco G; Gutiérrez-Fernández A; Costa D; Carrió A; Guijarro S; Enjuanes A; Hernández L; Yagüe J; Nicolás P; Romeo-Casabona CM; Himmelbauer H; Castillo E; Dohm JC; de Sanjosé S; Piris MA; de Alava E; San Miguel J; Royo R; Gelpí JL; Torrents D; Orozco M; Pisano DG; Valencia A; Guigó R; Bayés M; Heath S; Gut M; Klatt P; Marshall J; Raine K; Stebbings LA; Futreal PA; Stratton MR; Campbell PJ; Gut I; López-Guillermo A; Estivill X; Montserrat E; López-Otín C; Campo E
Nature; 2011 Jun; 475(7354):101-5. PubMed ID: 21642962
[TBL] [Abstract][Full Text] [Related]
7. Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma.
Pantic M; Schroettner P; Pfeifer D; Rawluk J; Denz U; Schmitt-Gräff A; Veelken H; Wäsch R; Engelhardt M
Leukemia; 2010 Apr; 24(4):885-90. PubMed ID: 20090779
[No Abstract] [Full Text] [Related]
8. [Cytogenetic disorders in chronic B-cell lymphoid leukemia and their relations with clinicobiological features and prognosis of the disease].
Zakharova AI; Obukhova TN; Lorie IuIu; Nikitin EA; Samoĭlova RS; Zingerman BV; Domracheva EV
Ter Arkh; 2006; 78(7):57-62. PubMed ID: 16944752
[TBL] [Abstract][Full Text] [Related]
9. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
Wiktor A; Van Dyke DL
Cancer Genet Cytogenet; 2004 Aug; 153(1):73-6. PubMed ID: 15325099
[TBL] [Abstract][Full Text] [Related]
10. Trisomy 8 as sole cytogenetic abnormality in a case of chronic lymphocytic leukemia.
Lau LC; Kee SK; Tien SL; Koh Mickey BC
Cancer Genet Cytogenet; 2007 Jan; 172(1):66-9. PubMed ID: 17175382
[TBL] [Abstract][Full Text] [Related]
11. A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.
Hernández JÁ; Hernández-Sánchez M; Rodríguez-Vicente AE; Grossmann V; Collado R; Heras C; Puiggros A; Martín AÁ; Puig N; Benito R; Robledo C; Delgado J; González T; Queizán JA; Galende J; de la Fuente I; Martín-Núñez G; Alonso JM; Abrisqueta P; Luño E; Marugán I; González-Gascón I; Bosch F; Kohlmann A; González M; Espinet B; Hernández-Rivas JM;
PLoS One; 2015; 10(11):e0143073. PubMed ID: 26630574
[TBL] [Abstract][Full Text] [Related]
12. Cryptic XPO1-MLLT10 translocation is associated with HOXA locus deregulation in T-ALL.
Bond J; Bergon A; Durand A; Tigaud I; Thomas X; Asnafi V; Spicuglia S; Macintyre E
Blood; 2014 Nov; 124(19):3023-5. PubMed ID: 25377562
[No Abstract] [Full Text] [Related]
13. Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma.
Navarro-Bailón A; Jiménez C; Alonso-Álvarez S; Alcoceba M; González-Calle V; Chillón MC; García-Álvarez M; Prieto I; Medina A; González M; Caballero MD; Blanco Ó; Díaz LG; García-Sanz R; Sarasquete ME
Hematol Oncol; 2019 Apr; 37(2):215-218. PubMed ID: 30548996
[No Abstract] [Full Text] [Related]
14. Absence of microsatellite instability in human chronic lymphocytic leukaemia B cells.
Praz F; Le Page F; Vallat L; Davi F; Nguyen-Khac F; Maloum K; Delic J; Merle-Béral H
Leukemia; 2008 Jan; 22(1):186-9. PubMed ID: 17673901
[No Abstract] [Full Text] [Related]
15. XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy.
Camus V; Miloudi H; Taly A; Sola B; Jardin F
J Hematol Oncol; 2017 Feb; 10(1):47. PubMed ID: 28196522
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric identification of 76 patients with biclonal disease among 5523 patients with chronic lymphocytic leukaemia (B-CLL) and its genetic characterization.
Kern W; Bacher U; Schnittger S; Dicker F; Alpermann T; Haferlach T; Haferlach C
Br J Haematol; 2014 Feb; 164(4):565-9. PubMed ID: 24236747
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytic clusters in peripheral blood: an atypical morphologic pattern of chronic lymphocytic leukemia.
Bizzaro N; Piazza I
Acta Haematol; 1991; 86(4):209-11. PubMed ID: 1805489
[TBL] [Abstract][Full Text] [Related]
20. [Some genomic aberrations in B-cell chronic lymphocytic leukemia and their clinical relevance. Part II. Trisomy 12 in B-cell chronic lymphocytic leukemia detected by fluorescence in situ hybridization].
Wasik-Szczepanek E; Rupniewska ZM; Koczkodaj D; Bojarska A
Pol Arch Med Wewn; 2003 Dec; 110(6):1431-8. PubMed ID: 15052938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
